90%Confidence
0Views
FDASource
2026-03-02Date
Summary
McKesson faces a Class I FDA recall for UDENYCA due to temperature abuse affecting 116 cartons, indicating potential supply chain quality control failures. This recall could disrupt patient access to this biosimilar medication and may impact McKesson's reputation as a pharmaceutical distributor.
Actionable: Monitor McKesson's supply chain quality reports and consider reviewing distributor relationships for temperature-sensitive products.
AI Confidence: 90%
Data Points
firmMcKesson
classificationClass I
statusOngoing
distributionNationwide in the USA
productUDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now